EP2423122B1 - Medicine bottles for removing pelletised bulk material - Google Patents

Medicine bottles for removing pelletised bulk material Download PDF

Info

Publication number
EP2423122B1
EP2423122B1 EP10450134.1A EP10450134A EP2423122B1 EP 2423122 B1 EP2423122 B1 EP 2423122B1 EP 10450134 A EP10450134 A EP 10450134A EP 2423122 B1 EP2423122 B1 EP 2423122B1
Authority
EP
European Patent Office
Prior art keywords
vial
opening
inner layer
weakening line
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP10450134.1A
Other languages
German (de)
French (fr)
Other versions
EP2423122A1 (en
Inventor
Wilhelm Ing. Zuser
Robert Afflenzer
Günter Ziegelwanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Constantia Teich GmbH
Original Assignee
Constantia Teich GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SI201031830T priority Critical patent/SI2423122T1/en
Priority to EP10450134.1A priority patent/EP2423122B1/en
Priority to HUE10450134A priority patent/HUE043120T2/en
Priority to PL10450134T priority patent/PL2423122T3/en
Priority to DK10450134.1T priority patent/DK2423122T3/en
Priority to PT10450134T priority patent/PT2423122T/en
Application filed by Constantia Teich GmbH filed Critical Constantia Teich GmbH
Priority to ES10450134T priority patent/ES2705205T3/en
Priority to US13/818,822 priority patent/US8991608B2/en
Priority to PCT/AT2011/000338 priority patent/WO2012024706A1/en
Publication of EP2423122A1 publication Critical patent/EP2423122A1/en
Application granted granted Critical
Publication of EP2423122B1 publication Critical patent/EP2423122B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0481—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills the articles passing through a small opening or passage, without additional dispensing devices and without retaining means for the following article

Definitions

  • the invention relates to a medicament vial for pills, dragees, tablets and other lumped presented contents, such as medicines, dietary supplements, flavoring, sweetening, coloring and preservatives as well as foods, such as cereals or nuts, which are loosely poured in the medicine vial, and especially a closure for such a vial according to the preamble of claim 1 and the WO2008 / 006123 A1 the applicant.
  • This document discloses a two-layer board for a container for liquids, wherein when opening the lower layer remains on the container and with the upper layer a circular part of the lower layer is peeled with, so that an opening for a drinking straw, etc. arises.
  • the disclosed material consists essentially of two interconnected layers, each of which may be multi-layered.
  • the inner layer is sealed with the respective container edge and has a self-contained line of weakness at a distance from the container edge.
  • the outer layer can be removed, usually by means of a tab. Since the bonding force between the two layers is less than the force connecting the inner layer in the seal area to the container rim, the two layers separate and the area of the inner layer that is delimited from the rest by the self-contained line of weakness remains the peeled outer layer adhere, so that an opening in the inner layer is released, which is substantially smaller than the part which covers the opening by the permanent seal with the container edge.
  • This technology is mainly used to avoid the spilling of liquid in vessels after the removal of the outer layer as possible and still provide a drinking opening or to provide an opening for a drinking straw or the like more.
  • This pamphlet was also called US 2009/0311475 A1 released.
  • these vials are closed by a screw cap with screw cap, which is provided as a guarantee of integrity at the time of purchase either a guarantee ring on the cap, which breaks when first screwing, or it is inside the cap, over the edge of the neck of the vial, a warranty board, usually made of aluminum or a plastic composite, sealed. This board must be peeled by the user if he wants to get to the contents of the vial, thus fulfilling the warranty function.
  • the use of such medicament vials for pharmaceuticals, dietary supplements, etc. actually represents an anachronism, considering that the production and filling of the packaging takes place in an environment that places nearly the same requirements on sterility and cleanliness as an operating room (operating room).
  • these objects are achieved by the features mentioned in the characterizing part of claim 1.
  • it consists of the closure not only from a screw or snap cap, but also from an at least two-layer board, which fulfills the warranty function and their removal an inner layer, optionally multilayer plastic film, remains at the edge of the opening, said Plastic film having a discharge opening, which is provided off-center on the circular film surface, and on the sealing edge facing side has at least one concave portion.
  • the Fig. 1 shows the medicine vial 1 with inventive closure in the closed state.
  • the Fig. 2 shows the medicine vial 1 of the Fig. 2 with removed screw cap and intact guarantee closure.
  • the Fig. 3 shows the medication vial 1 with the warranty cover removed and exposed opening 4 in an inner plastic film (3), which sticks after peeling off the guarantee closure on the edge of the drug vial 1 along a circumferential sealing edge 2 and covers the bottle opening in area 3 and only one opening 4 releases ,
  • the opening 4, which is delimited by a line of weakness 9, is arranged eccentrically to the circular sealing edge 2 or to its center and has on the side which is closest to the sealing edge 2, a concave portion. It is the area of the circumference of the opening 4, which lies between the points 5 and 6, which are the points of contact with a straight line 7.
  • the Fig. 4 shows the variant of the opening 4 according to the invention, very schematically, namely a plan view of an inner plastic film, as in Fig. 3 is trained.
  • the Fig. 5 shows a variant in which the tab 8 is significantly larger than that in Fig. 4 shown, with this tab 8 bends approximately in the region of the straight line 7 in the course of shaking out of tablets. It controls the dosage.
  • FIG. 7 shows a variant in which an approximately of a circle or an oval bounded opening 4 on the side of the periphery has a tab 8, which has approximately elliptical shape and is designed as a special feature beyond its major axis, so that the remaining opening 4 approximately sickle-shaped Has.
  • Fig. 8 shows an opening 4 which is delimited rectilinearly round, and the tab 8 has the shape of a triangle, which runs with its base along a chord of the circular sealing seam or the sealing edge 2 and whose tip is directed to the center of the board. Like the other tabs, so also bends this intended when shaking out a tablet and acts as braking and isolating.
  • the invention is not limited to the illustrated embodiments, but can be variously changed and adapted to the particular application.
  • the opening 4 is arranged eccentrically, as each user instinctively placed the opening in tilting and shaking the vial in the lower region, whereby in the inventive arrangement, the tab 8, which then protrudes from the edge up, perform their task best can.

Description

Die Erfindung betrifft ein Medikamentenfläschchen für Pillen, Dragees, Tabletten und anderes stückig dargebotenes Füllgut, wie Medikamente, Nahrungsergänzungsmittel, Aroma-, Süß-, Farb- und Konservierungsstoffe als auch Lebensmittel, wie Getreide oder Nüsse, die im Medikamentenfläschchen lose geschüttet vorliegen, und speziell einen Verschluss für ein derartiges Fläschchen entsprechend dem Oberbegriff des Anspruches 1 und der WO2008/006123 A1 der Anmelderin.
Diese Druckschrift offenbart eine zweischichtige Platine für einen Behälter für Flüssigkeiten, wobei beim Öffnen die untere Schicht am Behälter verbleibt und mit der oberen Schicht ein kreisförmiger Teil der unteren Schicht mit abgepeelt wird, sodass eine Öffnung für einen Trinkhalm, etc. entsteht. Das geoffenbarte Material besteht im Wesentlichen aus zwei miteinander verbundenen Schichten, die jeweils mehrlagig ausgebildet sein können. Die innere Schicht wird mit dem jeweiligen Behälterrand versiegelt und weist im Abstand vom Behälterrand eine in sich geschlossene Schwächungslinie auf. Die äußere Schicht kann, zumeist mittels einer Lasche, abgezogen werden. Da die Verbindungskraft zwischen den beiden Schichten kleiner ist als die Kraft, die die innere Schicht im Siegelbereich mit dem Behälterrand verbindet, trennen sich die beiden Schichten und der Bereich der inneren Schicht, der durch die in sich geschlossene Schwächungslinie vom Rest abgegrenzt ist, bleibt auf der abgezogenen äußeren Schicht haften, sodass eine Öffnung in der inneren Schicht freigegeben wird, die wesentlich kleiner ist als der Teil, der durch die bleibende Versiegelung mit dem Behälterrand die Öffnung abdeckt.The invention relates to a medicament vial for pills, dragees, tablets and other lumped presented contents, such as medicines, dietary supplements, flavoring, sweetening, coloring and preservatives as well as foods, such as cereals or nuts, which are loosely poured in the medicine vial, and especially a closure for such a vial according to the preamble of claim 1 and the WO2008 / 006123 A1 the applicant.
This document discloses a two-layer board for a container for liquids, wherein when opening the lower layer remains on the container and with the upper layer a circular part of the lower layer is peeled with, so that an opening for a drinking straw, etc. arises. The disclosed material consists essentially of two interconnected layers, each of which may be multi-layered. The inner layer is sealed with the respective container edge and has a self-contained line of weakness at a distance from the container edge. The outer layer can be removed, usually by means of a tab. Since the bonding force between the two layers is less than the force connecting the inner layer in the seal area to the container rim, the two layers separate and the area of the inner layer that is delimited from the rest by the self-contained line of weakness remains the peeled outer layer adhere, so that an opening in the inner layer is released, which is substantially smaller than the part which covers the opening by the permanent seal with the container edge.

Diese Technologie wird im Wesentlichen verwendet, um bei Gefäßen nach dem Abziehen der äußeren Schicht das Ausschütten von Flüssigkeit möglichst zu vermeiden und dennoch eine Trinköffnung zur Verfügung zu stellen oder um eine Öffnung für einen Trinkhalm zur Verfügung zu stellen oder dergleichen mehr. Diese Druckschrift wurde auch als US 2009/0311475 A1 veröffentlicht.This technology is mainly used to avoid the spilling of liquid in vessels after the removal of the outer layer as possible and still provide a drinking opening or to provide an opening for a drinking straw or the like more. This pamphlet was also called US 2009/0311475 A1 released.

Ähnliche Materialien mit ähnlicher Ausbildung, die zu gleichen Zwecken verwendet werden, sind aus der EP 812 782 A , der US 2004/0013827 A1 , der US 4 735 335 , der GB 2 027 664 A und aus der WO 2006/113951 A1 bekannt.Similar materials with similar training, which are used for the same purposes are from the EP 812 782 A , of the US 2004/0013827 A1 , of the US 4,735,335 , of the GB 2 027 664 A and from the WO 2006/113951 A1 known.

Diese Technologie wurde im Laufe der Zeit verschiedentlich weiterentwickelt und ausgestaltet und an verschiedene Anwendungsgebiete angepasst, doch wurde bis jetzt in keinem Fall die geschaffene Öffnung für einen anderen Zweck vorgesehen, als Zugang zum Behälterinneren zu schaffen. Dies beginnt bei der Herstellung besonders kleiner Öffnungen, durch die der Überdruck in Verpackungen, deren Inhalt im Mikrowellenherd erwärmt wird, entweichen bzw. abgebaut werden kann. Schon genannt wurden Zugangsöffnungen für Trinkhalme bzw. Trinköffnungen, weitere Öffnungen sind bekannt, um Flüssigkeiten auszugießen, dabei aber das Kochgut, beispielsweise Reis, zuverlässig zurückgehalten werden soll.
Vielfach werden die genannten Medikamente, Nahrungsergänzungsmittel, Vitaminpräparate etc. nicht einzeln in sogenannten Blisterverpackungen verpackt, sondern lose geschüttet in sogenannten Medikamentenfläschchen aus Glas oder in den letzten Jahren zunehmend bis fast ausschließlich aus Kunststoff verkauft.
Üblicherweise werden diese Fläschchen durch einen Schraubverschluss mit Schraubkappe verschlossen, wobei als Garantieerkennung für die Unversehrtheit zum Zeitpunkt des Kaufes entweder ein Garantiering an der Kappe vorgesehen ist, der beim erstmaligen Aufschrauben bricht, oder aber es ist im Inneren der Kappe, über den Rand des Halses des Fläschchens, eine Garantieplatine, zumeist aus Aluminium oder einem Kunststoffverbund, aufgesiegelt. Diese Platine muss vom Benutzer abgepeelt werden, wenn er zum Inhalt des Fläschchens gelangen will, und erfüllt so die Garantiefunktion.
Die Verwendung von solchen Medikamentenfläschchen für Pharmazeutika, Nahrungsergänzungsmittel etc. stellt eigentlich einen Anachronismus dar, wenn man bedenkt, dass die Herstellung und das Füllen der Verpackung in einer Umgebung erfolgt, die an Keimfreiheit und Sauberkeit nahezu die gleichen Anforderungen stellt wie ein OP (Operationssaal), und wenn man dann bedenkt, dass der Benutzer beim Versuch eine Tablette (es wird in der Folge aus Gründen der Einfachheit immer nur von Tablette(n) gesprochen und die anderen speziellen Bezeichnungen der einzelnen Darreichungsformen werden darunter stillschweigend mitverstanden) so gut wie immer mehrere Tabletten aus dem Fläschchen schüttelt (zumeist auf einen hygienisch durchaus bedenklichen Untergrund) und die, die er nicht benötigt, mit seinen bloßen Fingern, wieder zurück ins Fläschchen wirft, wo sie in vielen Fällen noch monatelang unbenutzt verbleiben, während der anhaftende Schweiß und Hautschuppen etc. in Zersetzung übergehen.
Da aber am Markt derartige Medikamentenfläschchen von den Endbenutzern nach wie vor stark nachgefragt werden und in vielen Fällen den ebenfalls angebotenen Blisterpackungen vorgezogen werden, besteht der Wunsch nach einer verbesserten Ausgabemöglichkeit für die Tabletten aus den Medikamentenfläschchen.
Es ist somit Aufgabe der Erfindung, einen Verschluss für ein solches Medikamentenfläschchen zu schaffen, der die Entnahme einzelner Tabletten erleichtert und das Ausleeren einer Vielzahl von Tabletten bei einer Schüttelbewegung zumindest im Wesentlichen verhindert.
Erfindungsgemäß werden diese Ziele durch die im kennzeichnenden Teil des Anspruchs 1 genannten Merkmale erreicht.
Mit anderen Worten, es besteht der Verschluss nicht nur aus einer Schraub- oder Schnappkappe, sondern auch aus einer zumindest zweischichtigen Platine, die die Garantiefunktion erfüllt und bei deren Abziehen eine innere Schicht, eine gegebenenfalls mehrlagige Kunststofffolie, am Rand der Öffnung verbleibt, wobei diese Kunststofffolie eine Ausgabeöffnung aufweist, die außermittig auf der kreisrunden Folienfläche vorgesehen ist, und auf der dem Siegelrand zugewandten Seite zumindest einen konkaven Abschnitt aufweist.This technology has been developed and developed variously over time and adapted to different fields of application, but has never been created the opening created for a purpose other than to provide access to the container interior. This begins with the production of particularly small openings, through which the overpressure in packages, the contents of which are heated in the microwave oven, can escape or be reduced. Already called access openings for drinking straws or drinking openings, other openings are known to pour out liquids, but the food, such as rice, should be reliably retained.
In many cases, the aforementioned drugs, supplements, vitamin supplements, etc. are not individually packaged in so-called blister packs, but loosely poured into so-called medicine vials made of glass or in recent years increasingly sold almost exclusively from plastic.
Usually, these vials are closed by a screw cap with screw cap, which is provided as a guarantee of integrity at the time of purchase either a guarantee ring on the cap, which breaks when first screwing, or it is inside the cap, over the edge of the neck of the vial, a warranty board, usually made of aluminum or a plastic composite, sealed. This board must be peeled by the user if he wants to get to the contents of the vial, thus fulfilling the warranty function.
The use of such medicament vials for pharmaceuticals, dietary supplements, etc. actually represents an anachronism, considering that the production and filling of the packaging takes place in an environment that places nearly the same requirements on sterility and cleanliness as an operating room (operating room). , and then considering that the user is tempted to use one tablet (for the sake of simplicity, it will be referred to only as tablet (s) hereinafter and the other specific names of the individual dosage forms are tacitly understood) as well as several Tablets from the vial shakes (usually on a hygienically quite questionable background) and those he does not need, with his bare fingers, back into the vial casts, where in many cases they remain unused for months, while the adhering sweat and dandruff, etc. go into decomposition.
However, since such bottles are still in high demand from end-users on the market and, in many cases, are also preferred over the blister packs also offered, there is a desire for an improved dispensing capability for the tablets from the medication bottles.
It is therefore an object of the invention to provide a closure for such a medicament vial, which facilitates the removal of individual tablets and prevents the emptying of a plurality of tablets in a shaking movement, at least substantially.
According to the invention, these objects are achieved by the features mentioned in the characterizing part of claim 1.
In other words, it consists of the closure not only from a screw or snap cap, but also from an at least two-layer board, which fulfills the warranty function and their removal an inner layer, optionally multilayer plastic film, remains at the edge of the opening, said Plastic film having a discharge opening, which is provided off-center on the circular film surface, and on the sealing edge facing side has at least one concave portion.

Auf diese Weise fungiert der von einer gedachten Geraden durch die beiden Enden des konkaven Abschnittes nach innen ragende Teil der Kunststofffolie als eine Art Bremse für die auszuleerenden Tabletten und erleichtert so die Entnahme einzelner Tabletten aus dem Medikamentenfläschchen.In this way, from an imaginary straight line through the two ends of the concave portion inwardly projecting part of the plastic film acts as a kind of brake for the tablets to be emptied, thus facilitating the removal of individual tablets from the drug vial.

Die Erfindung wird im Folgenden anhand der Zeichnung, die rein schematisch einige Ausführungsformen der Erfindung zeigt, näher dargestellt. Dabei zeigt bzw. zeigen:

  • die Fig. 1 ein Medikamentenfläschchen mit dem erfindungsgemäßen Verschluss in geschlossenem Zustand,
  • die Fig. 2 das Medikamentenfläschchen der Fig. 1 mit abgenommener Schraubkappe und intaktem Garantieverschluss,
  • die Fig. 3 eine Ansicht eines Medikamentenfläschchens wie in Fig. 1 bzw. 2 mit abgezogenem Garantieverschluss und freigelegter Entnahmeöffnung,
  • die Fig. 4 bis 8 verschiedene Formen erfindungsgemäßer Entnahmeöffnungen, rein schematisch in Draufsicht.
The invention will be described in more detail below with reference to the drawing, which purely schematically shows some embodiments of the invention. It shows or show:
  • the Fig. 1 a medicine vial with the closure according to the invention in the closed state,
  • the Fig. 2 the medicine bottle of the Fig. 1 with removed screw cap and intact guarantee closure,
  • the Fig. 3 a view of a medicine bottle as in Fig. 1 or 2 with withdrawn guarantee closure and exposed removal opening,
  • the Fig. 4 to 8 Various forms of extraction openings according to the invention, purely schematically in plan view.

Die Fig. 1 zeigt das Medikamentenfläschchen 1 mit erfindungsgemäßem Verschluss in geschlossenem Zustand.The Fig. 1 shows the medicine vial 1 with inventive closure in the closed state.

Die Fig. 2 zeigt das Medikamentenfläschchen 1 der Fig. 2 mit abgenommener Schraubkappe und intaktem Garantieverschluss.The Fig. 2 shows the medicine vial 1 of the Fig. 2 with removed screw cap and intact guarantee closure.

Die Fig. 3 zeigt das Medikamentenfläschchen 1 mit abgezogenem Garantieverschluss und freigelegter Öffnung 4 in einer inneren Kunststofffolie (3), die nach dem Abpeelen des Garantieverschlusses am Rand des Medikamentenfläschchens 1 entlang eines umlaufenden Siegelrandes 2 kleben bleibt und die Flaschenöffnung im Bereich 3 abdeckt und nur eine Öffnung 4 freigibt. Die Öffnung 4, die von einer Schwächungslinie 9 begrenzt ist, ist exzentrisch zum kreisförmigen Siegelrand 2 bzw. zu dessen Mittelpunkt angeordnet und weist auf der Seite, die dem Siegelrand 2 am nächsten liegt, einen konkaven Abschnitt auf. Es handelt sich dabei um den Bereich des Umfanges der Öffnung 4, der zwischen den Punkten 5 und 6 liegt, die die Berührungspunkte an eine Gerade 7 sind. Der Bereich 8, der zwischen dem Umfang der Öffnung 4 und der Geraden 7 liegt, dient als eine Art Lasche oder Zunge, die das Ausschütteln der Tabletten aus dem Medikamentenfläschchen gerade um so viel erschwert, dass die Anzahl der bei einer üblichen Ausschüttbewegung austretenden Tabletten stark reduziert und bevorzugt auf eine Tablette reduziert wird.
Die Fig. 4 zeigt die Variante der erfindungsgemäßen Öffnung 4, ganz schematisch, nämlich eine Draufsicht auf eine innere Kunststofffolie, wie sie in Fig. 3 ausgebildet ist.
Die Fig. 5 zeigt eine Variante, bei der die Lasche 8 deutlich größer ist als die in Fig. 4 gezeigte, wobei sich im Zuge des Ausschüttelns von Tabletten diese Lasche 8 etwa im Bereich der Geraden 7 biegt. Sie steuert so die Dosierung.The Fig. 3 shows the medication vial 1 with the warranty cover removed and exposed opening 4 in an inner plastic film (3), which sticks after peeling off the guarantee closure on the edge of the drug vial 1 along a circumferential sealing edge 2 and covers the bottle opening in area 3 and only one opening 4 releases , The opening 4, which is delimited by a line of weakness 9, is arranged eccentrically to the circular sealing edge 2 or to its center and has on the side which is closest to the sealing edge 2, a concave portion. It is the area of the circumference of the opening 4, which lies between the points 5 and 6, which are the points of contact with a straight line 7. The area 8, which lies between the periphery of the opening 4 and the straight line 7, serves as a kind of tab or tongue, which makes it difficult to shake out the tablets from the medicament bottle just so much that the number of tablets exiting in a conventional dispensing movement is high reduced and preferably reduced to one tablet.
The Fig. 4 shows the variant of the opening 4 according to the invention, very schematically, namely a plan view of an inner plastic film, as in Fig. 3 is trained.
The Fig. 5 shows a variant in which the tab 8 is significantly larger than that in Fig. 4 shown, with this tab 8 bends approximately in the region of the straight line 7 in the course of shaking out of tablets. It controls the dosage.

Andere Varianten, jeweils mit einem Maß h von Laschen 8 bezüglich einer Geraden 7, sind in den Fig. 6 bis 8 dargestellt, dabei zeigt die Fig. 6 eine Variante mit einer Öffnung 4, die durch zwei etwa radial verlaufende Ränder an den Seiten und zwei etwa in Umfangsrichtung verlaufende konkave Ränder, sowohl auf der dem Umfang 2 zugeordneten Seite, als auch auf der dem Zentrum zugeordneten Seite, begrenzt ist. Es sind somit zwei Laschen bei dieser Öffnung ausgebildet, durch die Tabletten bei der Schüttelbewegung beim Ausgeben wie durch zwei Lippen hindurch treten und so vereinzelt werden.
Fig. 7 zeigt eine Variante, bei der eine etwa von einem Kreis oder einem Oval begrenzte Öffnung 4 an der Seite der Peripherie eine Lasche 8 aufweist, die annähernde elliptische Form hat und dabei als Besonderheit über ihre Hauptachse hinaus ausgebildet ist, sodass die verbleibende Öffnung 4 annähernd Sichelform hat.Other variants, each with a measure h of tabs 8 with respect to a straight line 7, are in the Fig. 6 to 8 shown, while showing the Fig. 6 a variant with an opening 4, which is bounded by two approximately radially extending edges on the sides and two approximately circumferentially extending concave edges, both on the circumference 2 associated side, as well as on the center of the associated side. There are thus formed two tabs at this opening, through which tablets pass during the shaking motion during dispensing as though passing through two lips and thus are separated.
Fig. 7 shows a variant in which an approximately of a circle or an oval bounded opening 4 on the side of the periphery has a tab 8, which has approximately elliptical shape and is designed as a special feature beyond its major axis, so that the remaining opening 4 approximately sickle-shaped Has.

Fig. 8 zeigt eine Öffnung 4, die ringsum geradlinig begrenzt ist, und die Lasche 8 die Form eines Dreieckes hat, das mit seiner Basis entlang einer Sehne der kreisförmigen Siegelnaht bzw. dem Siegelrand 2 verläuft und dessen Spitze zum Zentrum der Platine gerichtet ist. Wie auch die anderen Laschen, so biegt sich auch diese bestimmungsgemäß beim Ausschütteln einer Tablette und wirkt so bremsend und vereinzelnd. Fig. 8 shows an opening 4 which is delimited rectilinearly round, and the tab 8 has the shape of a triangle, which runs with its base along a chord of the circular sealing seam or the sealing edge 2 and whose tip is directed to the center of the board. Like the other tabs, so also bends this intended when shaking out a tablet and acts as braking and isolating.

Die Erfindung ist nicht auf die dargestellten Ausführungsformen beschränkt, sondern kann verschiedentlich verändert und an die jeweilige Anwendung angepasst werden.The invention is not limited to the illustrated embodiments, but can be variously changed and adapted to the particular application.

In Kenntnis der Größe, der Masse, der Oberflächenbeschaffenheit und anderer Eigenschaften der Tabletten, die aus dem Medikamentenfläschchen entnommen werden sollen, ist es dem Fachmann auf dem Gebiet der Verpackungsindustrie anhand weniger Versuche möglich, die bestmögliche Form und Größe der Öffnung 4 zu bestimmen.Knowing the size, mass, surface finish and other properties of the tablets to be removed from the medication vial, it will be apparent to one skilled in the packaging industry that it will be possible to determine the best shape and size of the opening 4 on the basis of few attempts.

Da derartige Platinen im Stand der Technik für die eingangs genannten Zwecke bereits verschiedentlich bekannt sind, und diese vom Fachmann in Kenntnis der Erfindung leicht auf die erfindungsgemäße Anwendung übertragen werden können, ist es nicht notwendig, hier näher auf deren Aufbau und die dabei verwendeten Materialien einzugehen.Since such boards in the prior art for the purposes mentioned above are already variously known, and these can be easily transferred to the application of the invention by those skilled in the knowledge of the invention, it is not necessary here to detail their structure and the materials used ,

Bedeutsam ist, dass die Öffnung 4 außermittig angeordnet ist, da jeder Benutzer instinktiv die Öffnung beim Kippen und Schütteln des Fläschchens im unteren Bereich platziert, wodurch bei der erfindungsgemäßen Anordnung die Lasche 8, die dann vom Rand nach oben ragt, ihre Aufgabe am Besten erfüllen kann.Significantly, the opening 4 is arranged eccentrically, as each user instinctively placed the opening in tilting and shaking the vial in the lower region, whereby in the inventive arrangement, the tab 8, which then protrudes from the edge up, perform their task best can.

Claims (3)

  1. A vial (1) for tablets, pills, coated tablets, powders and other product in piecemeal form, such as drugs, food supplements, sweeteners, which are present in bulk in the vial (1), wherein the vial (1) is closed by means of a lid, said lid consisting of at least two layers, of which an inner layer (3), which may be of multi-ply configuration, is tightly sealed along the circumferential, circular rim of the vial (1) to the same and has eccentrically to the center of the circle a circumferential weakening line (9), and an outer layer, which may be of multi-ply configuration and is connected, such that it can be peeled off, to the inner layer (3), and wherein, when the peeling-off occurs, that region of the inner layer (3) which lies within the circumferential weakening line (9) remains on the outer layer and forms an opening (4) in the inner layer (3), characterized in that the circumferential weakening line (9) of the opening (4) has, in its region lying nearest to the sealing rim (2) a concave portion in form of a part (8) which protrudes, from a virtual chord of both ends of the concave portion, inwards into the opening (4) of the inner layer (3).
  2. The vial as claimed in claim 1, characterized in that the opening (4) to the region (3) has a convex region, in the form of a tab (8).
  3. The vial as claimed in claim 2, characterized in that the tab (8) is bounded by at least two points (5) and (6) on the weakening line (9) and a tangent (7) formed by these points (5) and (6).
EP10450134.1A 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material Not-in-force EP2423122B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HUE10450134A HUE043120T2 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material
PL10450134T PL2423122T3 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material
DK10450134.1T DK2423122T3 (en) 2010-08-25 2010-08-25 MEDICINAL FLACONS TO SELECT PIECE OF OFFERED PRODUCTS.
PT10450134T PT2423122T (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material
SI201031830T SI2423122T1 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material
ES10450134T ES2705205T3 (en) 2010-08-25 2010-08-25 Vials to spend products contained in fragmented form
EP10450134.1A EP2423122B1 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material
US13/818,822 US8991608B2 (en) 2010-08-25 2011-08-09 Vial for the removal of product contained in piecemeal form
PCT/AT2011/000338 WO2012024706A1 (en) 2010-08-25 2011-08-09 Pharmaceutical bottle for withdrawing goods that are in the form of pieces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10450134.1A EP2423122B1 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material

Publications (2)

Publication Number Publication Date
EP2423122A1 EP2423122A1 (en) 2012-02-29
EP2423122B1 true EP2423122B1 (en) 2018-10-10

Family

ID=43415781

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10450134.1A Not-in-force EP2423122B1 (en) 2010-08-25 2010-08-25 Medicine bottles for removing pelletised bulk material

Country Status (9)

Country Link
US (1) US8991608B2 (en)
EP (1) EP2423122B1 (en)
DK (1) DK2423122T3 (en)
ES (1) ES2705205T3 (en)
HU (1) HUE043120T2 (en)
PL (1) PL2423122T3 (en)
PT (1) PT2423122T (en)
SI (1) SI2423122T1 (en)
WO (1) WO2012024706A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017003953A2 (en) * 2015-06-26 2017-01-05 Bartley Investments Llc Pill bottle dispenser for dispensing one or two pills
WO2017031139A1 (en) 2015-08-17 2017-02-23 Csp Technologies, Inc. Container orifice reducer with tamper evident seal
US10569937B2 (en) * 2016-04-22 2020-02-25 Csp Technologies, Inc. Container orifice reducer with tamper evident seal
USD945767S1 (en) * 2019-04-12 2022-03-15 CaseMD, LLC Insulated medication container

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3204758A (en) * 1963-04-25 1965-09-07 Pfizer & Co C Pill container
US3880316A (en) * 1973-11-08 1975-04-29 Dayton Reliable Tool & Mfg Co Easy open push button ecology end
FR2435406A1 (en) 1978-08-08 1980-04-04 Boise Cascade Corp ADDED SHUTTER ELEMENT FOR PARTIALLY OPENING THE UPPER PART OF COMPOSITE CONTAINERS OR THE LIKE
US4735335A (en) 1985-08-06 1988-04-05 Etude Et Realisation De Chaines Automatiques-E.R.C.A. Composite band for lids for thermoplastic containers
DE8913356U1 (en) * 1989-11-11 1990-01-04 Hoffarth, Egmont, 2319 Grabensee, De
FR2734243B1 (en) 1995-05-16 1997-08-08 Alsacienne Aluminium COMPOSITE TAPE WITH RESILIENCE FOR THERMOPLASTIC CONTAINERS WITH PEEL OPENING
US5894950A (en) * 1997-10-15 1999-04-20 C.A.P.S. Inc. One-piece closure with re-closable break away lid
US20040013827A1 (en) 2000-05-04 2004-01-22 Wilhelm Zuser Thermally-sealable multilayer film for resealable packages
AT501789B1 (en) 2005-04-28 2007-07-15 Teich Ag METHOD FOR PRODUCING A COVER WITH REMOVAL OPENING
US7395928B2 (en) * 2005-07-14 2008-07-08 Abbott Laboratories Child-resistant blister package
FR2901253B1 (en) * 2006-05-19 2008-08-15 Airsec Soc Par Actions Simplif OPERATED STORAGE AND DISPENSING ASSEMBLY WITH FLOW LIMITER OF SOLID PHARMACEUTICAL PRODUCTS
AT9750U1 (en) 2006-07-13 2008-03-15 Teich Ag COMPOSITE MATERIAL, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS PACKAGING MATERIAL
US8408792B2 (en) * 2007-03-30 2013-04-02 Kraft Foods Global Brands Llc Package integrity indicating closure

Also Published As

Publication number Publication date
WO2012024706A1 (en) 2012-03-01
US20130264354A1 (en) 2013-10-10
SI2423122T1 (en) 2019-02-28
EP2423122A1 (en) 2012-02-29
ES2705205T3 (en) 2019-03-22
DK2423122T3 (en) 2019-01-28
HUE043120T2 (en) 2019-07-29
US8991608B2 (en) 2015-03-31
PL2423122T3 (en) 2019-04-30
PT2423122T (en) 2019-01-17

Similar Documents

Publication Publication Date Title
DE60310144T2 (en) SUPPLY VESSEL
EP2423122B1 (en) Medicine bottles for removing pelletised bulk material
EP1196336B1 (en) Blister pack
EP3071489B1 (en) Child resistant blow-fill seal container
US11021294B2 (en) Dispensing containers
EP1196333A1 (en) Child-proof packaging for tablets
EP1873078A1 (en) Liner with perforations
EP2323918B1 (en) Blister pack
EP2423123B1 (en) Medicine bottle for dispensing pelletised material
EP1144265A2 (en) Seal for a liquid container
AT517369B1 (en) Container and bandage from a number of containers
US10792221B2 (en) Dispensing containers
EP1847475A2 (en) Container for bulk goods
EP0264768B1 (en) Package, especially for cooking fat, cheese, etc.
DE60313676T2 (en) dispensing container
JP2007161260A (en) System and method for distributing single capsule-like object
EP3083422B1 (en) Vial for fluid products, particularly for medicinal, pharmaceutical, cosmetic, food products or the like
EP1357051A1 (en) Dispensing containers
DE1586540C (en) Packaging with a hinged lid
WO2012033473A1 (en) Container for packaging two components (variants)
RU106602U1 (en) CAPACITY FOR PACKING TWO COMPONENTS
WO2019121002A1 (en) Lightweight package
WO2017186949A1 (en) Body orifice administration device and method for producing same
DE102011081314A1 (en) Foil packaging with tear thread
EP1131250A1 (en) Tear-off opening for containers and cans

Legal Events

Date Code Title Description
AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME RS

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120829

17Q First examination report despatched

Effective date: 20160624

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20161122

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180525

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1050952

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

Ref country code: DE

Ref legal event code: R096

Ref document number: 502010015435

Country of ref document: DE

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Ref document number: 2423122

Country of ref document: PT

Date of ref document: 20190117

Kind code of ref document: T

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20190107

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20190123

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20181010

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2705205

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20190322

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190110

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190111

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010015435

Country of ref document: DE

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E043120

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

26N No opposition filed

Effective date: 20190711

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20190830

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20190823

Year of fee payment: 10

Ref country code: IT

Payment date: 20190828

Year of fee payment: 10

Ref country code: DK

Payment date: 20190830

Year of fee payment: 10

Ref country code: IE

Payment date: 20190822

Year of fee payment: 10

Ref country code: FR

Payment date: 20190828

Year of fee payment: 10

Ref country code: FI

Payment date: 20190823

Year of fee payment: 10

Ref country code: ES

Payment date: 20190916

Year of fee payment: 10

Ref country code: SI

Payment date: 20190823

Year of fee payment: 10

Ref country code: SE

Payment date: 20190823

Year of fee payment: 10

Ref country code: NO

Payment date: 20190827

Year of fee payment: 10

Ref country code: PT

Payment date: 20190822

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20190823

Year of fee payment: 10

Ref country code: BE

Payment date: 20190829

Year of fee payment: 10

Ref country code: HU

Payment date: 20190913

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20190827

Year of fee payment: 10

Ref country code: GB

Payment date: 20190830

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20190823

Year of fee payment: 10

Ref country code: DE

Payment date: 20191001

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190825

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502010015435

Country of ref document: DE

REG Reference to a national code

Ref country code: NO

Ref legal event code: MMEP

REG Reference to a national code

Ref country code: FI

Ref legal event code: MAE

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20200831

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20200901

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 1050952

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200825

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200825

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210325

Ref country code: FI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200826

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210302

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: SI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200826

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

REG Reference to a national code

Ref country code: SI

Ref legal event code: KO00

Effective date: 20210810

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200901

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181010

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200825